4:06 pm Prothena: First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson’s Disease; Entering clinic triggers $15 mln milestone payment from Roche
moreView todays social media effects on PRTAView the latest stocks trending across Twitter. Click to view dashboardSee who Prothena is hiring next, click here to view […]